Literature DB >> 3675471

Buspirone blocks motion sickness and xylazine-induced emesis in the cat.

J B Lucot1, G H Crampton.   

Abstract

Cats were tested for motion sickness following s.c. pretreatment with four doses of buspirone. Buspirone blocked motion sickness with an ED50 of 0.46 mg . kg-1 base. Buspirone pretreatment (4.0 mg . kg-1 base) also significantly blocked vomiting in cats later injected with 0.66 mg . kg-1 (base) s.c. of the emetic drug xylazine. The results are interpreted as showing that buspirone is acting at the vomiting center, the point of convergence for the separate mechanisms subserving chemically-induced emesis and motion sickness.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3675471

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  5 in total

1.  The effect on motion sickness and oculomotor function of GR 38032F, a 5-HT3-receptor antagonist with anti-emetic properties.

Authors:  J R Stott; G R Barnes; R J Wright; C J Ruddock
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

2.  Intravenous buspirone for the prevention of postoperative nausea and vomiting.

Authors:  Peter Kranke; Kerstin D Röhm; Pierre Diemunsch; Tong J Gan; Christian C Apfel; Leopold Eberhart; Harold S Minkowitz; Jan Wallenborn; Dominique Chassard; Gilles Lebuffe; Gabriel M Fox; Martin R Tramèr
Journal:  Eur J Clin Pharmacol       Date:  2012-05-01       Impact factor: 2.953

3.  The broad-spectrum antiemetic effects ETI-385 result from stimulation of 5-HT1A and 5-HT1D receptors.

Authors:  J B Lucot; R E L Brame; T L Garrett; E H Pfadenhauer; A Kumar; D B Fick; D R Helton
Journal:  Exp Brain Res       Date:  2014-06-10       Impact factor: 1.972

4.  5-HT1A agonists: alcohol drinking in rats and squirrel monkeys.

Authors:  Sara D McKenzie-Quirk; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2003-03-26       Impact factor: 4.530

5.  Identification of neural networks that contribute to motion sickness through principal components analysis of fos labeling induced by galvanic vestibular stimulation.

Authors:  Carey D Balaban; Sarah W Ogburn; Susan G Warshafsky; Abdul Ahmed; Bill J Yates
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.